Scripps Health's Eric Topol on Statins and Diabetes Risk
What is more important: The benefit of taking a cholesterol-lowering statin drug to protect against heart attacks and strokes, or the increased risk of developing diabetes that might accompany the medication in some patients?
While a new study concluded that the heart-disease prevention benefits outweigh the diabetes risk, Scripps Clinic cardiologist Eric Topol, M.D., continues to warn against over prescribing the popular drugs.
“Although there is a narrow trade-off with the benefits of reducing heart disease, this paper doesn’t mitigate the (diabetes) concern to me,” the Scripps Health chief academic officer told The Wall Street Journal in a recent article about the study.
Dr. Topol also weighed in on the controversy in coverage by USA Today and The Boston Globe.
Read those full articles here:
Media Contact
- Keith Darce
- 858-678-7121
- darce.keith@scrippshealth.org
- Follow me: @KeithDarce